SG11202007860XA - Pharmaceutical composition comprising timolol - Google Patents
Pharmaceutical composition comprising timololInfo
- Publication number
- SG11202007860XA SG11202007860XA SG11202007860XA SG11202007860XA SG11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA SG 11202007860X A SG11202007860X A SG 11202007860XA
- Authority
- SG
- Singapore
- Prior art keywords
- timolol
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18164563 | 2018-03-28 | ||
| EP18185436 | 2018-07-25 | ||
| PCT/EP2019/057429 WO2019185543A1 (en) | 2018-03-28 | 2019-03-25 | Pharmaceutical composition comprising timolol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007860XA true SG11202007860XA (en) | 2020-09-29 |
Family
ID=65818028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007860XA SG11202007860XA (en) | 2018-03-28 | 2019-03-25 | Pharmaceutical composition comprising timolol |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210121471A1 (en) |
| EP (1) | EP3773469A1 (en) |
| JP (1) | JP2021518352A (en) |
| KR (1) | KR20200136403A (en) |
| CN (1) | CN111867560A (en) |
| AU (1) | AU2019246035A1 (en) |
| BR (1) | BR112020017841A2 (en) |
| CA (1) | CA3091313A1 (en) |
| IL (1) | IL276888A (en) |
| MX (1) | MX2020010078A (en) |
| SG (1) | SG11202007860XA (en) |
| WO (1) | WO2019185543A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11684589B2 (en) | 2016-09-22 | 2023-06-27 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
| WO2018055101A1 (en) | 2016-09-23 | 2018-03-29 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| CA3076776A1 (en) | 2017-09-27 | 2019-04-04 | Novaliq Gmbh | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases |
| KR20200128407A (en) | 2018-03-02 | 2020-11-12 | 노바리크 게엠베하 | Pharmaceutical composition containing nebivolol |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19536504C2 (en) * | 1995-09-29 | 1999-09-23 | H Meinert | Use of fluorinated alkanes |
| US6335335B2 (en) | 1997-11-05 | 2002-01-01 | Senju Pharmaceutical Co., Ltd. | Prolonged-action eye drop |
| TWI298257B (en) * | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
| US7030149B2 (en) * | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
| WO2003099258A1 (en) * | 2002-05-24 | 2003-12-04 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol |
| US20070238732A1 (en) * | 2006-04-10 | 2007-10-11 | Allergan, Inc. | Brimonidine and timolol compositions |
| EP2178502A2 (en) * | 2007-06-21 | 2010-04-28 | Yale University | Sustained delivery of drugs from biodegradable polymeric microparticles |
| EP2444063A1 (en) * | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| EP2462921A1 (en) * | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| JP2012250951A (en) * | 2011-06-06 | 2012-12-20 | Santen Pharmaceut Co Ltd | COMBINATION AGENT OF ADENOSINE DERIVATIVE, PROSTAGLANDIN AND β-RECEPTOR BLOCKER |
| JP6704400B2 (en) * | 2014-10-20 | 2020-06-03 | センティス・ファーマ・プライヴェート・リミテッド | Ophthalmic solution |
| WO2016082644A1 (en) * | 2014-11-26 | 2016-06-02 | The University Of Hong Kong | A semifluorinated alkane based cleaner for removing emulsified droplets in the eye to reduce the complications associated with the emulsification of silicone oil |
| PL3442480T3 (en) * | 2016-06-23 | 2020-04-30 | Novaliq Gmbh | Topical administration method |
-
2019
- 2019-03-25 WO PCT/EP2019/057429 patent/WO2019185543A1/en unknown
- 2019-03-25 SG SG11202007860XA patent/SG11202007860XA/en unknown
- 2019-03-25 AU AU2019246035A patent/AU2019246035A1/en active Pending
- 2019-03-25 KR KR1020207027430A patent/KR20200136403A/en not_active Application Discontinuation
- 2019-03-25 MX MX2020010078A patent/MX2020010078A/en unknown
- 2019-03-25 US US17/041,758 patent/US20210121471A1/en active Pending
- 2019-03-25 JP JP2020549581A patent/JP2021518352A/en active Pending
- 2019-03-25 CA CA3091313A patent/CA3091313A1/en active Pending
- 2019-03-25 CN CN201980018538.6A patent/CN111867560A/en active Pending
- 2019-03-25 EP EP19711929.0A patent/EP3773469A1/en active Pending
- 2019-03-25 BR BR112020017841-1A patent/BR112020017841A2/en unknown
-
2020
- 2020-08-24 IL IL276888A patent/IL276888A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019246035A1 (en) | 2020-09-10 |
| MX2020010078A (en) | 2021-02-26 |
| JP2021518352A (en) | 2021-08-02 |
| CN111867560A (en) | 2020-10-30 |
| CA3091313A1 (en) | 2019-10-03 |
| WO2019185543A1 (en) | 2019-10-03 |
| IL276888A (en) | 2020-10-29 |
| EP3773469A1 (en) | 2021-02-17 |
| US20210121471A1 (en) | 2021-04-29 |
| KR20200136403A (en) | 2020-12-07 |
| BR112020017841A2 (en) | 2020-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279442A (en) | Pharmaceutical compositions comprising meloxicam | |
| GB201807942D0 (en) | Pharmaceutical formulation | |
| IL269061A (en) | Pharmaceutical composition comprising selexipag | |
| PL3452075T3 (en) | Ophthalmic pharmaceutical composition | |
| IL276888A (en) | Pharmaceutical composition comprising timolol | |
| GB201804548D0 (en) | Pharmaceutical compositions | |
| EP3851121A4 (en) | Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition | |
| IL290894A (en) | Pharmaceutical formulation | |
| GB201807053D0 (en) | Pharmaceutical composition | |
| SG11202103374TA (en) | Pharmaceutical composition | |
| GB201911517D0 (en) | Pharmaceutical composition | |
| GB201808571D0 (en) | Pharmaceutical compositions | |
| EP3603641A4 (en) | Pharmaceutical composition containing dusp1 inhibitor | |
| SG11202110315SA (en) | Pharmaceutical composition | |
| FI3908321T3 (en) | Pharmaceutical composition | |
| IL280989A (en) | Pharmaceutical compositions comprising integration-promoting peptides | |
| EP4081251A4 (en) | Pharmaceutical compositions | |
| GB201906473D0 (en) | Pharmaceutical formulation | |
| GB201808567D0 (en) | Pharmaceutical compositions | |
| EP3664798A4 (en) | Pharmaceutical composition comprising eliglustat | |
| ZA202006541B (en) | Pharmaceutical composition comprising brexpiprazole | |
| IL285728A (en) | Pharmaceutical composition | |
| GB201912686D0 (en) | Pharmaceutical composition | |
| GB201908003D0 (en) | Pharmaceutical composition | |
| GB201820689D0 (en) | Pharmaceutical composition |